Advancing Medical Research

Our bodies delicately balance clotting and anti-clotting mechanisms, which help to stop bleeding when there’s an injury or dissolve dangerous clots that can form in blood vessels.

But for patients with hemophilia, a rare genetic disease that causes deficiencies in clotting factor VIII or IX, this…

For children with achondroplasia, the most common type of dwarfism, scientists are exploring new ways to restore bone growth and potentially address some of the major health complications with the condition, such as spinal problems, swelling in the brain, frequent ear infections and sleep apnea.

Achondroplasia is a rare genetic bone disorder affecting…

When biologics to treat inflammatory bowel disease (IBD) were first released over two decades ago, they greatly improved quality of life for many patients. But these first-generation therapies have their shortcomings. Fewer than half of patients treated with these inflammation-blocking drugs will be in remission after one year of treatment. These treatments can also suppress the immune system, making patients…

Since the human genome was first sequenced in 2003, scientists have collected a wealth of genetic information that could potentially be used to help create new medicines. Remarkably, as sequencing technology gets faster and cheaper, the amount of human genetic data now doubles every seven…

Every year, millions of people get the flu shot. Although the vaccine provides protection for many people, some people still get the flu, in part, because the influenza vaccine production cycle starts at least six months in advance of the flu season. And while the World Health Organization’s selection is based on surveillance data collected from around the world, the strains in the vaccine do not always match those…